Press Releases

NEW YORK, Oct. 1, 2019 /PRNewswire/ -- Koneksa Health, a private company that enables the biopharmaceutical industry to develop new medicines using digital biomarkers and novel clinical endpoints, announced today the publication of a peer-reviewed manuscript demonstrating the utility of  wearable devices for monitoring clinical-trial subjects for physiological

BOSTON, Oct. 1, 2019 /PRNewswire/ -- Stealth BioTherapeutics Corp (NASDAQ: MITO), a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel therapies for diseases involving mitochondrial dysfunction, today announced that Reenie McCarthy, Chief Executive Officer, will present at the 2019 C

LOS ANGELES, Oct. 1, 2019 /PRNewswire/ -- Today, Antech Diagnostics, part of Mars Petcare, released a new diagnostic tool that was developed using artificial intelligence to analyze pet medical record data to predict whether a cat will develop chronic kidney disease (CKD) up to two years before traditional clinical diagnosis.

MONTREAL, Oct. 1, 2019 /PRNewswire/ - Chronometriq, the Montreal-based provider of access-to-ca

ATLANTA, Oct. 1, 2019 /PRNewswire/ -- Advanced Medical Pricing Solutions (AMPS) announced today that 2019 was a year of aggressive, if behind-the-scenes, growth for the company. Under the leadership of Kirk Fallbacher, AMPS CEO and President, the pioneer in cost containment has stayed singularly focused on building out the infrastructure an

SALT LAKE CITY, Oct. 1, 2019 /PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders, announced today that data from a clinical trial of LPCN 1144 in non-alcoholic fatty liver disease ("NAFLD") will be presented at

NEW YORK, Oct. 1, 2019 /PRNewswire/ -- Hospital for Special Surgery (HSS), world leader in orthopedics and rheumatology, has appointed an expert in healthcare transformation to lead an emerging musculoskeletal ecosystem propelled by HSS expertise, knowledge and care delivery. HSS president and CEO Louis A. Shapiro today announced the appoin

HOUSTON, Oct. 1, 2019 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson Cancer Center ("MD Anderson"), today announced it has completed all patient treatments in t

SAN FRANCISCO, Oct. 1, 2019 /PRNewswire/ -- Bay Labs, a growing medical technology company applying deep learning technology to emulate the expertise of highly-trained medical experts, announced today that it has achieved a number of significant milestones, including renaming the company to Caption Health, effective immediately. The company has also renamed their fl

MALVERN, Pa., Oct. 1, 2019 /PRNewswire/ -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders, is spotlighting the many faces and stories of depression to encourage an open dialogue and awareness of